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Background. We studied women and their infants to evaluate risk factors for congenital transmission and
cardiomyopathy in Trypanosoma cruzi–infected women.
Methods. Women provided data and blood for serology and quantitative polymerase chain reaction (PCR).
Infants of infected women had blood tested at 0 and 1 month by microscopy, PCR and immunoblot, and serology
at 6 and 9 months. Women underwent electrocardiography (ECG).
Results. Of 1696 women, 456 (26.9%) were infected; 31 (6.8%) transmitted T. cruzi to their infants. Women who
transmitted had higher parasite loads than those who did not (median, 62.0 [interquartile range {IQR}, 25.8–204.8] vs
0.05 [IQR, 0–29.6]; P < .0001). Transmission was higher in twin than in singleton births (27.3% vs 6.4%; P = .04). Women
who had not lived in infested houses transmittedmore frequently (9.7% vs 4.6%; P = .04), were more likely to have positive
results by PCR (65.5% vs 33.9%; P < .001), and had higher parasite loads than those who had lived in infested houses
(median, 25.8 [IQR, 0–64.1] vs 0 [IQR, 0–12.3]; P < .001). Of 302 infected women, 28 (9.3%) had ECG abnormalities
consistent with Chagas cardiomyopathy; risk was higher for older women (odds ratio [OR], 1.06 [95% conﬁdence interval
{CI}, 1.01–1.12] per year) and those with vector exposure (OR, 3.7 [95% CI, 1.4–10.2]). We observed a strong dose-
response relationship between ECG abnormalities and reported years of living in an infested house.
Conclusions. We hypothesize that repeated vector-borne infection sustains antigen exposure and the consequent in-
ﬂammatory response at a higher chronic level, increasing cardiac morbidity, but possibly enabling exposed women to
control parasitemia in the face of pregnancy-induced Th2 polarization.
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In the Americas, Trypanosoma cruzi causes the highest
disease burden of any parasite, accounting for 7 times
more disability-adjusted life years lost than malaria [1].
An estimated 6 million people are infected, of whom
20%–30% will develop potentially life-threatening
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heart disease [2]. Chagas cardiomyopathy is characterized by a
chronic inﬂammatory process [3]. The earliest signs are
usually conduction system abnormalities, followed by atrio-
ventricular blocks, ventricular arrhythmias, sinus node
dysfunction, and progressive dilated cardiomyopathy [4, 5].
The determinants of progression to cardiomyopathy are not
well understood, but may include repeated T. cruzi superinfec-
tion, parasite virulence and tissue tropism, and host immune
response [3].
Although vector exposure remains the most frequent infec-
tion route, T. cruzi can also be transmitted by transfusion or
transplantation, and from mother to child [6]. The Southern
Cone Initiative has made major advances in blood screening
and control of the principal vector, Triatoma infestans [7].
With the decrease in other routes, congenital transmission
has become proportionately more important, accounting for
an estimated 22% of new infections in 2010 [2]. In meta-
analyses, the median transmission rate from T. cruzi–infected
women is estimated at 5% [8], but rates vary widely, from 1%
to >15% across study populations [9–12].
From 2010 to 2013, we conducted a study of women and
their infants in 2 sites in Santa Cruz Department, Bolivia.
The ability to study congenital T. cruzi transmission and cardiac
status in the same women enabled us to examine the epidemi-
ology of these 2 phenomena simultaneously. Our aims were to
evaluate the incidence of vertical transmission and prevalence
of early cardiomyopathy in T. cruzi–infected women, and to
assess risk factors for both of these outcomes.
MATERIALS AND METHODS
Ethics Statement
The protocol was approved by the institutional review boards of
the Johns Hopkins Bloomberg School of Public Health, Hospi-
tal Universitario Japonés, Universidad Católica Boliviana,
Universidad Peruana Cayetano Heredia, Asociación Benéﬁca
Proyectos en Informatica, Salud, Medicina y Agricultura, and
the Centers for Disease Control and Prevention. Each woman
provided written informed consent for herself and her infant.
Study Population and Data and Specimen Collection
The study was conducted in Hospital Universitario Japonés in
urban Santa Cruz (city population 1.7 million) and Hospital
Municipal Camiri in Camiri (city population 30 191) (www.
ine.gob.bo) [13, 14]. Both hospitals are referral centers with a
large proportion of cesarean deliveries. Although vector-borne
T. cruzi transmission is absent in urbanized areas, both cities
receive migrants from rural areas with intense transmission. Ca-
miri is the capital of Cordillera province (population 111 171)
in the Bolivian Chaco and located a few miles from villages
where 50%–100% of houses are heavily infested, with rapid
reinfestation after insecticide application [14, 15]. The estimated
national T. cruzi prevalence is 6% [2], but in rural areas of the
Chaco, the all-age prevalence is 50%, and adult infection prev-
alence reaches ≥80% [14, 16].
Trained study nurses enrolled women presenting for delivery
and collected data, including a record of all houses lived in
throughout the woman’s life, duration of residence, construc-
tion materials, and observed vector infestation. The study in-
strument was developed and validated in earlier studies in
Santa Cruz [13, 17]; 2 nurses involved in the earlier validation
supervised the interviews. Blood was collected, centrifuged, and
immediately screened by 2 rapid tests, Trypanosoma Detect
(InBios, Seattle, Washington) and Polychaco indirect hemag-
glutination assay (IHA) at a single dilution of 1:16 (Lemos
Laboratories, Santiago del Estero, Argentina). Sera were later
tested in Santa Cruz by IHA with multiple dilutions and Cha-
gatest lysate enzyme-linked immunosorbent assay (ELISA),
with Recombinante 3.0 ELISA as a tie-breaker (both from Wie-
ner Laboratories, Rosario, Argentina). A conﬁrmed infection
required positive results by ≥2 conventional tests [18]. For
infected women, a standard 12-lead electrocardiogram (ECG)
was performed during a follow-up visit.
Management of Congenital T. cruzi Infection
A study nurse attended the delivery of each rapid test–positive
woman to collect cord blood. Infants of infected women had
follow-up blood collection at 1, 6, and 9 months of age. Cord
blood and 1-month specimens were examined by micromethod,
the standard technique to diagnose congenital T. cruzi infection
in the ﬁrst months of life in most Latin American healthcare fa-
cilities [19]. Blood is collected in 4–6 heparinized microhema-
tocrit tubes, sealed, and processed within 24 hours by
centrifugation (12 000 rpm for 7 minutes) followed by micros-
copy. Six- and 9-month specimens were centrifuged, and serum
samples were tested by immunoglobulin G assays as described
above for maternal testing.
Western blots were performed in our Lima laboratory to
detect immunoglobulin M (IgM) to trypomastigote excreted-
secreted antigens (IgM TESA-blot) in infant specimens follow-
ing published methods [20]. Blots with clear bands at the
expected molecular weights were considered positive; blots
with weak or ambiguous bands were repeated. Ladder-like
bands at 130–200 kDa on IgM TESA-blot demonstrate antibod-
ies to shed acute-phase antigens, indicating acute or congenital
infection [20]. In our earlier analysis, the TESA-blot showed
67% sensitivity and 100% speciﬁcity [13].
Quantitative polymerase chain reaction (PCR) was per-
formed on maternal and infant specimens in Lima. For the
ﬁrst 598 women and the ﬁrst 1000 infants in the study, phe-
nol-chloroform extractions were performed from blood clot
[13]. DNA was ampliﬁed using the primer set Cruzi1/Cruzi2
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following published methods [13, 21]. Parasite loads were calcu-
lated based on the standard curve included in each run; the
threshold of detection was estimated at 1 parasite equivalent/
mL. For later specimens, extractions were conducted using the
automated Qiacube system with Qiagen kits (Qiagen N.V.,
Hilden, Germany). The assay was restandardized following
this change, but analysis showed that the amount of DNA ex-
tracted was much lower, and sensitivity, especially for maternal
specimens whose parasite loads were relatively low, dropped
signiﬁcantly. For this reason, analyses related to maternal
parasite load are limited to the specimens extracted by phe-
nol-chloroform. Parasite loads were much higher in infant spec-
imens, and the diagnosis of congenital infection was based on
multiple samples and assays (Supplementary Table 1). We are
therefore conﬁdent that the infections included in this analysis
are true infections, and believe that few, if any, congenital infec-
tions were missed based on the methodological change.
A neonatologist (M. C. A.) managed infected infants follow-
ing Bolivian Control Program guidelines, which require positive
results by micromethod or serology at 6–9 months [22]. For this
analysis, we considered an infant to have congenital infection
based on positive results by >1 assay or positive serology at 6–
9 months conﬁrmed by IHA and ELISA. Infants with border-
line serological results at 6 months were asked to return for
repeat testing at 9 months.
Electrocardiographic Readings
Two cardiologists blinded to each other’s reading evaluated
each ECG and recorded abnormalities following standardized
methods [23]. We considered the following to be consistent
with Chagas cardiomyopathy: complete right or left bundle
branch block, left anterior or posterior fascicular block, complex
or multiform ventricular premature beats, atrioventricular
blocks in absence of drugs slowing AV conduction, sinus brady-
cardia <45 beats/minute or sinus pauses >3.0, atrial ﬁbrillation,
junctional rhythm, or complex ventricular arrhythmias (multi-
form, couplets, or nonsustained ventricular tachycardia). In-
complete right bundle branch block was not considered to
meet the criteria, because this ﬁnding can be a normal variant
in young individuals [24].
Data Analysis
Variables related to vector exposure were derived from the list-
ing of residences, construction material, and infestation. Statis-
tical analyses were performed using SAS software for Windows
9.0. Categorical variables were compared by χ2 or Fisher exact
test as appropriate. Continuous variables were analyzed using
the Wilcoxon rank-sum test. Multivariable models were con-
structed using forward stepwise logistical regression, testing var-
iables with P < .10 in univariate analyses. Model ﬁt was assessed
by the Akaike information criterion.
RESULTS
A total of 1696 women were screened for Chagas disease, 1213
in Santa Cruz between 1 June 2010 and 31May 2013, and 483 in
Camiri between 8 October 2012 and 5 March 2013. Women
who delivered in Camiri were more likely to have T. cruzi infec-
tion than those in Santa Cruz (47.4% vs 18.7%, respectively;
P < .0001; Table 1). The difference in prevalence was signiﬁcant
within every maternal age group (P < .001 for 3 younger age
groups; P < .01 for women 40–46 years old) (Figure 1). Women
delivering in Camiri were slightly younger than those in Santa
Cruz, and more likely to report having lived in infested houses
and in houses with mud walls and earth ﬂoors, materials asso-
ciated with vector infestation.
Thirty-four infants from 31 women were diagnosed with con-
genital T. cruzi infection (Supplementary Table 1). Congenital
transmission occurred to 3 sets of twins; all 6 babies were infected.
Three of 7 dichorionic twin births had transmission compared with
0 of 4 monochorionic twin births (P = .24). Infection status was in-
conclusive for 7 infants, 2 with borderline 6-month serology who
were treated by the national program before results could be repeat-
ed, and 5 with a single positive result by PCR with threshold cycle
close to the cutoff who failed to return for subsequent testing. The
mothers of these 7 infants were excluded from further analyses.
Women who transmitted to their infants were signiﬁcantly
more likely to have positive results by PCR and had higher par-
asite loads compared to those without transmission (Table 2).
Other signiﬁcant predictors included younger maternal age
and twin births. Mothers of infected infants were signiﬁcantly
less likely to report residence in an infested house, with an in-
verse relationship between residence duration and transmission
risk. Variables associated with domestic infestation such as mud
walls showed similar associations.
Women without reported residence in an infested house had
a higher transmission rate than those with this reported expo-
sure (20/207 [9.7%] vs 11/241 [4.6%]; P = .04). Women with no
history of living in an infested house were more likely to have
positive results by PCR (36/55 [65.5%] vs 21/62 [33.9%];
P < .001) and had higher parasite loads than those with a history
of residence in an infested house (median, 25.8 [interquartile
range {IQR}, 0–64.1] vs 0 [IQR, 0–12.3]; P < .001). The multi-
variable model failed to converge because all women who trans-
mitted had positive PCR results.
Of 302 T. cruzi–infected women with ECG data, 28 (9.3%)
showed at least 1 abnormality consistent with Chagas cardio-
myopathy (Supplementary Table 2). The most common abnor-
malities were bundle branch block and bradycardia. One
woman had right bundle branch block, intermittent complete
atrioventricular block, bradycardia, and junctional escape
rhythm; she developed hypotension requiring vasopressors
and received a pacemaker shortly after delivery [25].
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Compared to women with normal ECGs, women with abnor-
mal ECGs were older and more likely to report living in an
infested house at any time and at the time of study (Table 3).
The median duration of residence in an infested house was sig-
niﬁcantly longer for women with abnormal ECGs than those
with normal ECGs (17.5 vs 1.0 years; P = .001). Other variables
associated with house infestation showed similar associations.
Women with ECG abnormalities were less likely than those
with normal ECGs to transmit to their infants, but this associ-
ation was not statistically signiﬁcant (1/28 [3.6%] vs 22/274
[8.0%]; P = .40). There was no signiﬁcant difference in parasite
load for those with and without ECG abnormalities. In a mul-
tivariable model, increasing maternal age and residence in an
infested house were associated with 5% and 4% increased risk,
respectively, of ECG abnormalities per year of exposure
(Table 4). A second multivariable model estimated a 3.7-fold
increased risk of ECG abnormalities among women who ever
lived in an infested house vs those who had not.
The presence of ECG abnormalities demonstrated a strong
dose-response relationship with increasing years of living in
an infested house, whereas congenital transmission showed a
strong dose-response relationship for maternal parasite load
(Table 5). Congenital transmission risk was signiﬁcantly lower
for women in older age strata and those with longer duration of
residence in an infested house.
Table 1. Characteristics of Women Presenting for Delivery in Hospital Municipal Camiri, Camiri, and Hospital Japonés, Santa Cruz,
Bolivia
Maternal Characteristics Camiri (n = 483), No. (%) Santa Cruz (n = 1213), No. (%) Total (N = 1696), No. (%) P Value
Trypanosoma cruzi infection 229 (47.4) 227 (18.7) 456 (26.9) <.0001
Cesarean delivery 233 (48.5) 565 (46.6) 798 (47.1) .47
Twin births 4 (0.8) 19 (1.6) 23 (1.4) .35
Congenital transmissiona 8 (1.7) 23 (1.9) 31 (1.8) .74
Ever lived in rural areab 246 (51.0) 606 (52.2) 852 (51.9) .66
Lives in rural area now 160 (33.1) 311 (25.6) 471 (27.8) .002
Ever lived in an infested housec 165 (34.2) 293 (24.2) 458 (27.1) <.0001
Lives in infested house now 107 (22.2) 74 (6.1) 181 (10.7) <.0001
Ever lived in mud-wall house 210 (43.5) 410 (33.8) 620 (36.0) .0002
Lives in mud-wall house now 139 (28.8) 51 (4.2) 190 (11.2) <.0001
Ever lived in house with earth floor 212 (43.9) 405 (33.4) 617 (36.4) <.0001
Lives in house with earth floor now 139 (28.8) 58 (4.8) 197 (11.6) <.0001
Completed secondary school 225 (46.6) 426 (35.1) 651 (38.4) <.0001
Lives in house with electricity 404 (83.6) 1194 (98.4) 1598 (94.2) <.0001
Owns televisiond 369 (76.4) 1156 (95.4) 1525 (90.0) <.0001
Owns refrigeratore 253 (52.4) 814 (67.2) 1067 (37.0) <.0001
Owns motor vehiclee 76 (15.7) 164 (13.5) 240 (14.2) .25
Owns computere 85 (17.6) 76 (6.3) 161 (9.5) <.0001
a Data excluded for 3 women from Camiri and 4 women from Santa Cruz because infant infection status was unresolved (see text).
b Data missing for 1 woman from Camiri and 53 women from Santa Cruz.
c Data missing for 3 women from Santa Cruz.
d Data missing for 1 woman from Santa Cruz.
e Data missing for 2 women from Santa Cruz.
Figure 1. Trypanosoma cruzi infection prevalence by age among preg-
nant women in Santa Cruz and Camiri, Bolivia. The numbers above each
bar show the denominator for that age group. The difference in prevalence
between sites was signiﬁcant within every maternal age group (P < .001 for
the 3 younger age groups; P < .01 for women aged 40–46 years).
Vector Exposure and Chagas Disease • CID 2015:61 (15 September) • 921
DISCUSSION
Bolivia has the highest T. cruzi infection prevalence in the world
[18].More than 70% of cases of congestive heart failure in some
Santa Cruz hospitals are attributed to Chagas disease, and an
estimated 1 in 175 Bolivian infants is born with T. cruzi [17,
18]. In the Bolivian Chaco, people continue to live in infested
houses, and in some villages, 80%–90% of adults have Chagas
disease [14, 16]. In this setting, we examined factors associated
with early Chagas cardiomyopathy and congenital transmission
among women presenting for delivery. We observed a higher
prevalence of ECG abnormalities in women with longer resi-
dence times in infested houses, conﬁrming the impression of
longtime Chagas disease researchers [26, 27]. Remarkably, vec-
tor exposure variables showed an inverse relationship with
maternal parasitemia and mother-to-child transmission. Our
data thus suggest that sustained vector exposure increases the
risk of Chagas cardiomyopathy, but may be associated with
some protection against congenital transmission.
We hypothesize that both pathogenic and protective effects
may result from frequent exposure to infected vectors and re-
peated superinfection by the parasite [26]. In the acute phase
of Chagas disease, a robust inﬂammatory response involving in-
nate immune cells and macrophages activated by interferon
gamma (IFN-γ) and tumor necrosis factor alpha (TNF-α)
brings the parasitemia under control [28]. Acute symptoms
resolve spontaneously as patent parasitemia disappears, but
without treatment, total parasite clearance virtually never occurs
[18]. During chronic infection, T-cell–mediated immunity keeps
the parasite in check [29]. However, failure to downregulate the
Table 2. Factors Associated With Congenital Transmission Among Trypanosoma cruzi–Infected Women Presenting for Delivery in Camiri
Municipal Hospital, Camiri, and Hospital Japonés, Santa Cruz, Bolivia
Factor Transmitted T. cruzi (n = 31) Did Not Transmit T. cruzi (n = 418) P Valuea
Positive results by PCRb 13 (100) 44 (41.9) <.0001
Cesarean section 19 (61.3) 204 (48.8) .18
Twin birth 3 (9.7) 8 (1.9) .04
Primiparous 6 (19.4) 86 (20.6) .87
Parity >3 19 (61.3) 237 (56.7) .62
Ever lived in rural area 24 (77.4) 263 (64.6)c .15
Lives in rural area now 15 (48.4) 142 (34.0) .11
Ever lived in an infested house 11 (35.5) 230 (55.2)d .04
Lives in infested house now 4 (12.9) 98 (23.4) .26
Ever lived in house with mud walls 12 (38.7) 243 (58.1) .04
Lives in house with mud walls now 4 (12.9) 100 (23.9) .19
Ever lived in house with earth floor 13 (41.9) 242 (57.9) .09
Lives in house with earth floor now 5 (16.1) 100 (23.9) .39
Completed secondary school 6 (19.4) 141 (33.7) .11
Lives in house with electricity 30 (96.8) 363 (86.8) .16
Owns television 30 (96.8) 334 (80.1)d .02
Owns refrigerator 17 (54.8) 218 (52.3)d .78
Owns motor vehicle 2 (6.5) 48 (11.5) .56
Owns computer 0 (0) 42 (10.1) .10
Age, y, median (IQR) 24.0 (20.1–30.2) 26.8 (22.0–34.0) .04e
Parasite equivalents/mL by quantitative PCRb, median (IQR) 62.0 (25.8–204.8) 0.05 (0–29.6) <.0001e
Years living in rural area, median (IQR) 15.0 (0–22.0) 12.0 (0–21) .30e
Years living in infested house, median (IQR) 0 (0–15) 6.5 (0–20) .02e
Years living in house with mud walls, median (IQR) 0 (0–15) 8 (0–20) .02e
Years living in house with earth floor, median (IQR) 0 (0–17) 8 (0–20) .07e
Data are presented as No. (%) unless otherwise specified.
Abbreviations: IQR, interquartile range; PCR, polymerase chain reaction.
a By χ2 or Fisher exact test.
b Data available for 13 women who transmitted and 105 women who did not transmit.
c Data missing for 11 women.
d Data missing for 1 woman.
e By Wilcoxon rank-sum test for continuous variables.
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Table 3. Factors Associated With Electrocardiographic Abnormalities Consistent With Chagas Cardiomyopathy Among 302 Trypanosoma
cruzi–Infected Women
Maternal Characteristic Abnormal ECG (n = 28) Normal ECG (n = 274) P Valuea
Positive results by PCRb 3 (30.0) 33 (45.2) .50
Ever lived in rural area 18 (64.3) 175 (65.8)c .87
Lives in rural area now 12 (42.9) 85 (31.0) .20
Ever lived in an infested house 23 (82.1) 142 (51.8) .002
Lives in infested house now 10 (35.7) 49 (17.9) .03
Ever lived in house with mud walls 21 (75.0) 152 (55.5) .05
Lives in house with mud walls now 11 (39.3) 52 (19.0) .03
Ever lived in house with earth floor 21 (75.0) 151 (55.1) .04
Lives in house with earth floor now 11 (39.3) 50 (18.3) .008
Completed secondary school 11 (39.3) 98 (35.8) .71
Lives in house with electricity 24 (85.7) 243 (88.7) .55
Owns television 22 (78.6) 230 (84.3)d .42
Owns refrigerator 16 (57.1) 152 (55.7)d .88
Owns motor vehicle 1 (3.6) 37 (13.5) .23
Owns computer 5 (17.9) 26 (9.5) .19
Age, y, median (IQR) 32 (24–39) 27 (22–34) .03e
Parasite equivalents/mL by quantitative PCRb, median (IQR) 0 (0–27) 0.3 (0–33.7) .33e
Years lived in rural area, median (IQR) 14 (0–28) 10 (0–20)c .39e
Years lived in infested house, median (IQR) 17.5 (8–28) 1 (0–18) .001e
Years lived in house with mud walls, median (IQR) 17.5 (1.5–27) 5 (0–18) .01e
Years lived in house with earthen floor, median (IQR) 18.5 (1.5–28) 5 (0–18) .01e
Data are presented as No. (%) unless otherwise specified.
Abbreviations: ECG, electrocardiogram; IQR, interquartile range; PCR, polymerase chain reaction.
a By χ2 or Fisher exact test.
b PCR data available for 10 women with abnormal ECG and 73 women with normal ECG.
c Data missing for 9 women.
d Data missing for 1 woman.
e By Wilcoxon rank-sum test.
Table 4. Logistic Regression Model of Factors Associated With Electrocardigraphic Abnormalities Consistent With Chagas
Cardiomyopathy Among 302 Trypanosoma cruzi–Infected Women
Factor
Univariable Analyses Multivariable Model 1 Multivariable Model 2
OR (95% CI) P Value
Adjusted ORa
(95% CI) P Value
Adjusted ORa
(95% CI) P Value
Per year of age 1.07 (1.02–1.13) .012 1.06 (1.01–1.12) .04 1.05 (.99–1.12) .10
Ever lived in infested house 4.3 (1.6–11.6) .004 3.7 (1.4–10.2) .01 . . .
Lives in infested house now 2.6 (1.1–5.9) .03 . . . . . .
Per year of living in infested house 1.05 (1.02–1.08) .002 . . . 1.04 (1.01–1.07) .02
Ever lived in house with mud walls 2.4 (.99–5.9) .05 . . . . . .
Lives in house with mud walls now 2.8 (1.2–6.3) .02 . . . . . .
Per year in house with mud walls 1.04 (1.01–1.08) .008 . . . . . .
Ever lived in house with earth floor 2.4 (1.0–5.9) .05 . . . . . .
Lives in house with earth floor now 2.9 (1.3–6.6) .01 . . . . . .
Per year in house with earth floor 1.04 (1.01–1.07) .008 . . . . . .
Abbreviations: CI, confidence interval; OR, odds ratio.
a OR adjusted for the other variables listed in the column.
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inﬂammatory response, triggered by parasite persistence and
modulated by both host and parasite factors, is thought to play
a key role in the pathogenesis of Chagas cardiomyopathy [3,
28]. Mice superinfected with the same or a different T. cruzi
strain had more frequent, severe ECG changes [30]. Repeated
vector-borne infection is thought to sustain antigen exposure
and the consequent Th1-mediated inﬂammatory response at a
higher chronic level, increasing cardiac morbidity [3, 26].
In our data, reported time living in an infested house was in-
versely related to maternal parasitemia, which in turn is the stron-
gest immediate predictor of congenital transmission [13, 31, 32].
Repeated antigen exposure may reinforce the Th1 response that
controls the parasite in the face of the maternal Th2 polarization
necessary to maintain the pregnancy [33]. Only 2 previous
studies have examined vector exposure as a factor in congenital
transmission [34, 35]. An Argentine study reported ﬁndings
similar to ours; women from areas with high infestation rates
had the lowest risk of transmission compared with those from
areas under vector control (who had intermediate risk) and
those living in a city that had never had vector-borne transmis-
sion (the highest risk group) [34]. A Bolivian study reported
lower morbidity in infected infants of mothers in areas currently
under vector control, but no difference in the transmission rate
[35]. In our data, duration of residence showed a much stronger
association than current house infestation, suggesting that the
effect may require prolonged, repeated exposure to develop.
Parasite load was by far the strongest predictor of transmission.
Vector exposure is likely one of several factors that inﬂuence risk.
Other determinants may include T. cruzi genotype and tropism,
and maternal immunogenetics [36]. The predominant genotype
detected in congenital infections in Bolivia and Argentina is T.
cruzi V, followed by II and VI; no differences have been found
in transmission rates by genotype [32, 37]. Studies show lower
levels of TNF-α in mothers who transmit than those without
transmission [38]. Similarly, lower levels of T-cell and macro-
phage activation markers and T. cruzi–induced IFN-γ release
were found in mothers who transmitted compared with infected
mothers of uninfected infants [39].The association of twin births
with increased transmission may be related to the intensiﬁed
downregulation in multiple pregnancies [40].
Our study had a number of limitations. Our measures of vec-
tor exposure were retrospective and self-reported. Because T.
cruzi infection is chronic and usually acquired in childhood,
studies of adults necessarily assess exposures that occurred
years before data collection. However, T. infestans is a memora-
ble vector: Adults are >1 inch long, have a pungent odor, and
leave visible fecal trails on the walls of infested houses. Light in-
festations are more likely to have been missed than heavy ones.
Some women without reported residence in an infested house
were likely infected congenitally themselves, whereas others un-
doubtedly had more transient or less intense vector exposure
not captured in our data. Intensity (number of infective bites
Table 5. Dose-Response Analyses for Congenital Trypanosoma cruzi Transmission and Electrocardiographic Abnormalities Consistent
With Chagas Cardiomyopathy
Characteristic
Congenital Transmission,
no./No.(%) Stratum OR
χ2 for Trend,
P Value
Abnormal ECG
no./No. (%) Stratum OR
χ2 for Trend,
P Value
Age group
13–19 7/60 (11.7) Referent 3/35 (8.6) Referent
20–29 16/215 (7.4) 0.61 8/138 (5.8) 0.66
30–46 8/174 (4.6) 0.36 4.22, P= .04 18/133 (13.5) 1.67 2.3, P= .13
Years in infested house
None 20/207 (9.7) Referent 5/138 (3.6) Referent
1–19 9/134 (6.7) 0.67 11/96 (11.5) 3.44
≥20 2/107 (1.9) 0.18 7.12, P= .008 13/72 (18.1) 5.86 11.2, P= .0008
Parasite loada
0 0/61 (0)b Referent 7/47 (14.9)c Referent
1–34 4/24 (14.3) . . . 2/19 (10.5) 0.67
≥35 9/29 (31.0) . . . 18.0, P< .0001 1/17 (5.9) 0.36 1.5, P= .23
Increasing parasite load shows a direct dose-response relationship, whereas increasing maternal age and duration of vector exposure show an inverse relationship
with congenital T. cruzi transmission risk. Increasing duration of living in an infested house shows a direct dose-response relationship with the presence of ECG
abnormalities.
Abbreviations: ECG, electrocardiogram; OR, odds ratio.
a Parasite equivalents/mL by quantitative polymerase chain reaction (PCR).
b Data available for 13 women who transmitted and 105 who did not transmit. ORs undetermined because of 0 cell in referent stratum.
c PCR data available for 10 women with abnormal ECG and 73 women with normal ECG.
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per unit time) is impossible to assess retrospectively, but likely
plays a role in the effects we observed. We had technical difﬁ-
culties when we changed extraction methodology midway
through the study and were only able to include PCR data
from a subset of women. This impeded our ability to analyze
epidemiologic risk factors together with parasite load in multi-
variable models. Our cardiac analysis would have been strength-
ened by the addition of an uninfected control group, but this
was not feasible in the current study. However, we used rigorous
criteria to deﬁne ECG abnormalities, and all analyses were
comparisons within the group of infected mothers. In a meta-
analysis of population-based studies, the prevalence of bundle
branch blocks in women aged <45 years was 0.2% [41], com-
pared with 6.6% in study women, suggesting that the observed
abnormalities were due to Chagas disease. Our study enrolled
nearly 1700 women; an even larger sample size would have in-
creased our statistical power but would have strained our resourc-
es. Even in this high-prevalence population, we screened an
average of 54 women and conducted follow-up on 15 mother–
infant pairs to yield a single transmission event.
Chagas disease researchers have long postulated that repeated
T. cruzi superinfection is a major determinant of cardiomyopathy
risk [26, 27]. In areas under effective vector control, there is a
widespread impression that cardiomyopathy severity is lower,
and onset and mortality are delayed until later in life [42, 43].
Our maternal ECG data provide epidemiologic support for this
hypothesis, and underscore the importance of the vector control
effort in the Bolivian Chaco. Nevertheless, congenital transmis-
sion risk will remain as long as there are infected women in
the reproductive age group. Recent data give strong support to
the contention that antitrypanosomal treatment of women
prior to pregnancy markedly decreases congenital transmission
risk [44]. Sustained vector control efforts, especially in the most
affected communities, and programs to safely treat infected indi-
viduals are essential to decrease morbidity and prevent continued
congenital transmission in the future. Treatment of children and
young adults should be given high priority in Latin America and
other regions with infected residents [44, 45].
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